KEGG   DRUG: Drospirenone - ethinylestradiol betadex mixtHelp
Entry
D09741            Mixture   Drug                                   

Name
Drospirenone - ethinylestradiol betadex mixt;
Drospirenone - ethinylestradiol mixt;
Angeliq (TN);
Yaz (TN);
Flexyess (TN)
Product
  Generic
Component
Drospirenone [DR:D03917], (Ethinylestradiol betadex | Ethinylestradiol [DR:D00554])
Remark
Therapeutic category: 
ATC code: 
Activity
Menstruation disorder agent
Interaction
Genomic biomarker: CYP2C19 [HSA:1557]
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 G GENITO URINARY SYSTEM AND SEX HORMONES
  G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
   G03F PROGESTOGENS AND ESTROGENS IN COMBINATION
    G03FA Progestogens and estrogens, fixed combinations
     G03FA17 Drospirenone and estrogen
      D09741  Drospirenone - ethinylestradiol betadex mixt
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  24  Hormones
   248  Mixed hormone preparations
    2482  Estrogens and progestins
     D09741  Drospirenone - ethinylestradiol betadex mixt
Endocrine and hormonal agents [br08373.html]
 Hormone related agents
  D09741
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D09741
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D09741
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09741
Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
 Polymorphisms and germline mutations
  D09741
BRITE hierarchy
Other DBs
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system